HIGHLIGHTS
- who: Hélène Lê et al. from the Transgène SA, Boulevard Gonthier d'Andernach, Illkirch-Graffenstaden, France Faculty of Medicine and Pharmacy, University Hospital Strasbourg, Place de l'Hôpital have published the Article: Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine, in the Journal: Biomedicines 2022, 1677 of 17/03/2022
SUMMARY
Lung cancer is the deadliest cancer worldwide; non-small cell lung cancer (NSCLC) is the most common form, with 85% of all cases. The survival rate over 5 years for patients with advanced . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.